Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
Clinical trial NCT01313273 · TERMINATED
Trial details
- NCT number
- NCT01313273
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.